NASDAQ:CBLI - Cleveland BioLabs Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cleveland BioLabs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.03 -0.05 (-2.40 %) (As of 02/18/2020 10:38 AM ET) Add Compare Today's Range$2.02Now: $2.03▼$2.0850-Day Range$0.58MA: $1.65▼$4.2352-Week Range$0.50Now: $2.03▼$4.90Volume3,095 shsAverage Volume2.09 million shsMarket Capitalization$22.94 millionP/E RatioN/ADividend YieldN/ABeta-0.47 ProfileAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cleveland BioLabs, Inc, a biopharmaceutical company, develops novel approaches to activate the immune system and address various medical needs in the United States and Russia. Its proprietary platform of toll-like immune receptor activators (TLR) has applications in radiation mitigation, oncology immunotherapy, and vaccines. The company's product candidate is entolimod, an immune-stimulatory agent, which is used as a medical radiation countermeasure and an immunotherapy for oncology and other indications. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Commercial physical research Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CBLI Previous Symbol CUSIPN/A CIK1318641 Webhttp://www.cbiolabs.com/ Phone716-849-6810Debt Debt-to-Equity RatioN/A Current Ratio3.87 Quick Ratio3.87Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$1.14 million Price / Sales20.12 Cash FlowN/A Price / Cash FlowN/A Book Value$0.32 per share Price / Book6.34Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-3,610,000.00 Net Margins-241.79% Return on Equity-93.20% Return on Assets-69.62%Miscellaneous EmployeesN/A Outstanding Shares11,300,000Market Cap$22.94 million Next Earnings Date3/5/2020 (Estimated) OptionableNot Optionable Receive CBLI News and Ratings via Email Sign-up to receive the latest news and ratings for CBLI and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:CBLI Rates by TradingView Cleveland BioLabs (NASDAQ:CBLI) Frequently Asked Questions What is Cleveland BioLabs' stock symbol? Cleveland BioLabs trades on the NASDAQ under the ticker symbol "CBLI." How were Cleveland BioLabs' earnings last quarter? Cleveland BioLabs, Inc. (NASDAQ:CBLI) posted its earnings results on Wednesday, November, 14th. The biotechnology company reported ($0.10) earnings per share for the quarter. The biotechnology company had revenue of $0.28 million for the quarter. Cleveland BioLabs had a negative return on equity of 93.20% and a negative net margin of 241.79%. View Cleveland BioLabs' Earnings History. When is Cleveland BioLabs' next earnings date? Cleveland BioLabs is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Cleveland BioLabs. Has Cleveland BioLabs been receiving favorable news coverage? News coverage about CBLI stock has been trending neutral recently, according to InfoTrie. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cleveland BioLabs earned a news impact score of 0.4 on InfoTrie's scale. They also assigned media headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Cleveland BioLabs. Are investors shorting Cleveland BioLabs? Cleveland BioLabs saw a drop in short interest in January. As of January 31st, there was short interest totalling 27,200 shares, a drop of 43.0% from the January 15th total of 47,700 shares. Based on an average daily volume of 280,400 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.6% of the company's shares are short sold. View Cleveland BioLabs' Current Options Chain. Who are some of Cleveland BioLabs' key competitors? Some companies that are related to Cleveland BioLabs include Bioanalytical Systems (BASI), BIOQUAL (BIOQ), HedgePath Pharmaceuticals (HPPI), Tenax Therapeutics (TENX), US Stem Cell (USRM), Vitality Biopharma (VBIO), Protalex (PRTX), ALGAE TEC LTD/S (ALGXY) and Redpoint Bio (RPBC). What other stocks do shareholders of Cleveland BioLabs own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cleveland BioLabs investors own include Inovio Pharmaceuticals (INO), Nektar Therapeutics (NKTR), Sorrento Therapeutics (SRNE), Anavex Life Sciences (AVXL), Cidara Therapeutics (CDTX), Corbus Pharmaceuticals (CRBP), Progenics Pharmaceuticals (PGNX), Actinium Pharmaceuticals (ATNM), Novavax (NVAX) and Tonix Pharmaceuticals (TNXP). Who are Cleveland BioLabs' key executives? Cleveland BioLabs' management team includes the folowing people: Dr. Yakov N. Kogan M.B.A., Ph.D., MBA, CEO & Interim Principal Financial Officer (Age 46)Dr. Langdon L. Miller, Pres & Chief Medical Officer (Age 65)Dr. Andrei V. Gudkov, Chief Scientific Officer (Age 63)Dr. Ann Lenich Hards Ph.D., Exec. VP of Regulatory AffairsDr. Andrei Purmal Ph.D., VP of Chemistry How do I buy shares of Cleveland BioLabs? Shares of CBLI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Cleveland BioLabs' stock price today? One share of CBLI stock can currently be purchased for approximately $2.03. How big of a company is Cleveland BioLabs? Cleveland BioLabs has a market capitalization of $22.94 million and generates $1.14 million in revenue each year. View Additional Information About Cleveland BioLabs. What is Cleveland BioLabs' official website? The official website for Cleveland BioLabs is http://www.cbiolabs.com/. How can I contact Cleveland BioLabs? Cleveland BioLabs' mailing address is 73 HIGH STREET, BUFFALO NY, 14203. The biotechnology company can be reached via phone at 716-849-6810 or via email at [email protected] MarketBeat Community Rating for Cleveland BioLabs (NASDAQ CBLI)Community Ranking: 3.2 out of 5 ( )Outperform Votes: 264 (Vote Outperform)Underperform Votes: 146 (Vote Underperform)Total Votes: 410MarketBeat's community ratings are surveys of what our community members think about Cleveland BioLabs and other stocks. Vote "Outperform" if you believe CBLI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBLI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/18/2020 by MarketBeat.com StaffFeatured Article: Initial Coin Offering (ICO)
